Bioequivalence and Bioavailability Forum 04:51 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

jag009
Hero

NJ,
2013-10-30 20:15

Posting: # 11824
Views: 4,330
 

 Anyone going to AAPS Nov 10 – 14? [Conferences / Workshops]

Just curious to know.

Thanks
John
ElMaestro
Hero

Denmark,
2013-10-30 20:23

@ jag009
Posting: # 11825
Views: 3,657
 

 Anyone going to AAPS Nov 10 – 14?

Oh yeah:


Roundtable
Global Clinical Regulatory Requirements for Inhalation Products
9:00 AM Thursday Nov 14
Room 006AB

Come by and say hello!

if (3) 4

Best regards,
ElMaestro

"(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures." New York Times (ed.), June 9, 2018.
jag009
Hero

NJ,
2013-10-30 21:30

@ ElMaestro
Posting: # 11826
Views: 3,607
 

 Anyone going to AAPS Nov 10 – 14?

ElMaestro,

» Roundtable
» Global Clinical Regulatory Requirements for Inhalation Products
» 9:00 AM Thursday Nov 14
» Room 006AB
»
» Come by and say hello!

Would love to but flight at 8AM!
Any chance we and others can meet somewhere?

John
ElMaestro
Hero

Denmark,
2013-10-31 19:34

@ jag009
Posting: # 11847
Views: 3,527
 

 Anyone going to AAPS Nov 10 – 14?

Hi John,

» Would love to but flight at 8AM!
» Any chance we and others can meet somewhere?

I'll be there from Sat. Nov. 9 and the entire week.
Everything is possible.

if (3) 4

Best regards,
ElMaestro

"(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures." New York Times (ed.), June 9, 2018.
Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
18,939 posts in 4,040 threads, 1,288 registered users;
online 8 (0 registered, 8 guests [including 5 identified bots]).

Outside his own ever-narrowing field of specialization,
a scientist is a layman.
What members of an academy of science have in common
is a certain form of semiparasitic living.    Erwin Chargaff

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed